Interleukin-13 is involved in the survival of children with sepsis

Area of Science:

• Pediatric critical care medicine
• Immunology
• Infectious diseases

Background:

• Sepsis is a life-threatening condition in children.
• Interleukin-13 (IL-13) is a Th-2 cytokine involved in allergic inflammation.
• The role of IL-13 in pediatric sepsis is not well understood.

Purpose of the Study:

• To investigate the association between IL-13 levels and clinical outcomes in pediatric sepsis.
• To determine if IL-13 levels correlate with disease severity, mortality, or refractory shock.

Main Methods:

• Prospective study of 48 children diagnosed with sepsis.
• Measurement of IL-13 levels at admission and 6 hours.
• Comparison of IL-13 levels between survivors and non-survivors, and patients with and without refractory shock.
• Correlation analysis with other inflammatory markers (IL-1b, IL-10, IL-12, TNFr, CRP, neutrophil count).

Main Results:

• Lower IL-13 levels were observed in patients who died compared to survivors at admission (p=0.014) and 6 hours (p=0.037).
• Patients with refractory shock had significantly lower IL-13 levels at 0 hours (p=0.03) and 6 hours (p=0.0009).
• IL-13 levels did not correlate with other measured cytokines, CRP, or neutrophil counts.

Conclusions:

• Low IL-13 levels in the early stages of pediatric sepsis are associated with poor prognosis.
• IL-13 may have a protective role against severe infections in children, distinct from its role in atopy.